BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34780078)

  • 1. Association of reduced maternal sHLA-G5 isoform levels and elevated TNF-α/IL-4 cytokine ratio with Recurrent Pregnancy Loss: A study on South Indian women.
    Madduru D; Dirsipam K; Goli M; Ramana Devi V; Jahan P
    Scand J Immunol; 2021 Oct; 94(4):e13095. PubMed ID: 34780078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. sHLA-G1 and HLA-G5 levels are decreased in Tunisian women with multiple abortion.
    Zidi I; Rizzo R; Bouaziz A; Laaribi AB; Zidi N; Di Luca D; Tlili H; Bortolotti D
    Hum Immunol; 2016 Apr; 77(4):342-5. PubMed ID: 26812178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between decreased plasma levels of soluble human leukocyte antigen-G and severe pre-eclampsia.
    He Y; Chen S; Huang H; Chen Q
    J Perinat Med; 2016 Apr; 44(3):283-90. PubMed ID: 26352061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
    Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
    Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of serum soluble HLA-G levels in patients with acute ischemic stroke: A pilot study.
    Fainardi E; Bortolotti D; Castellazzi M; Casetta I; Bellini T; Rizzo R
    Hum Immunol; 2020 Apr; 81(4):156-161. PubMed ID: 31735441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble HLA-G blood levels are not increased during ongoing pregnancy in women with a history of recurrent pregnancy loss.
    Krop J; Van Der Keur C; Kapsenberg JM; Den Hollander F; Van Der Hoorn MLP; Heidt S; Claas FHJ; Eikmans M
    J Reprod Immunol; 2022 Sep; 153():103665. PubMed ID: 35905658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the concentration of sHLA-I and selected cytokines in pregnancy complicated by antiphospholipid syndrome.
    Olimpia SS; Magdalena P; Tomasz P; Piotr W; Elzbieta RW
    Ginekol Pol; 2011 May; 82(5):354-8. PubMed ID: 21851034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.
    Rebmann V; Lemaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
    Hum Immunol; 2005 Aug; 66(8):853-63. PubMed ID: 16216668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial estimation of Th1:th2 cytokines profile in women undergoing in-vitro fertilization-embryo transfer.
    Kalu E; Bhaskaran S; Thum MY; Vishwanatha R; Croucher C; Sherriff E; Ford B; Bansal AS
    Am J Reprod Immunol; 2008 Mar; 59(3):206-11. PubMed ID: 18275514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
    Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
    Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UP-regulated levels of sHLA-G in women with a history of RPL in mid-gestation presumably to achieve ongoing pregnancy.
    Jahan P; Bhuwalka R; Begum M; Madduru D; Ahmad A; Bonu R
    Am J Reprod Immunol; 2023 Dec; 90(6):e13798. PubMed ID: 38009053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen (HLA)-G during pregnancy part I: correlations between maternal soluble HLA-G at midterm, at term, and umbilical cord blood soluble HLA-G at term.
    Klitkou L; Dahl M; Hviid TV; Djurisic S; Piosik ZM; Skovbo P; Møller AM; Steffensen R; Christiansen OB
    Hum Immunol; 2015 Apr; 76(4):254-9. PubMed ID: 25636573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for HLA-G in the induction of regulatory T cells during the maintenance of a healthy pregnancy?
    Al-Khunaizi NR; Tabbara KS; Farid EM
    Am J Reprod Immunol; 2020 Aug; 84(2):e13259. PubMed ID: 32352606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of intravenous immunoglobulin therapy in treating unexplained recurrent spontaneous abortion and its effect on the level of serum soluble human leucocyte antigen G].
    Sun XG; Liu XY; Zhu R; Fan GS; Zhang Y; Chen FL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Oct; 32(5):483-7. PubMed ID: 21050549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-G polymorphisms and soluble HLA-G protein levels in women with recurrent pregnancy loss from Basrah province in Iraq.
    Jassem RM; Shani WS; Loisel DA; Sharief M; Billstrand C; Ober C
    Hum Immunol; 2012 Aug; 73(8):811-7. PubMed ID: 22651916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in pre-eclampsia.
    Darmochwal-Kolarz D; Kolarz B; Rolinski J; Leszczynska-Gorzelak B; Oleszczuk J
    Folia Histochem Cytobiol; 2012 Jul; 50(2):286-91. PubMed ID: 22763960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture.
    Kanai T; Fujii T; Kozuma S; Yamashita T; Miki A; Kikuchi A; Taketani Y
    Mol Hum Reprod; 2001 Feb; 7(2):195-200. PubMed ID: 11160846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HLA-G 14 bp insertion/deletion polymorphism and its association with soluble HLA-G levels in women with recurrent miscarriages.
    Kalotra V; Lall M; Verma IC; Kaur A; Kaur A
    HLA; 2018 Mar; 91(3):167-174. PubMed ID: 29280596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the impact of SOCS3, IL-35 and IL17 in immune pathogenesis of recurrent pregnancy loss?
    Ozkan ZS; Deveci D; Simsek M; Ilhan F; Risvanli A; Sapmaz E
    J Matern Fetal Neonatal Med; 2015 Feb; 28(3):324-8. PubMed ID: 24762139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble HLA-G concentrations in obese women during pregnancy and in cord blood.
    Beneventi F; Locatelli E; De Amici M; Martinetti M; Spinillo A
    J Reprod Immunol; 2017 Feb; 119():31-37. PubMed ID: 27984763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.